Quantcast

Latest Clinical research Stories

2014-07-25 00:21:04

REDWOOD CITY, Calif., July 24, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today confirmed the PDUFA date for Zalviso remains July 27, 2014. The company recently learned that a rumor circulated online stating the Food and Drug Administration (FDA) had approved Zalviso. As of July 24, 2014 there has been...

2014-07-24 23:13:47

DZS Clinical Services announced today that SBI Pharmaceuticals, the leading expert in research, development, and manufacturing of 5-ALA, has entered into a preferred provider agreement with DZS to manage several clinical programs related to the development of 5-ALA. Bound Brook, NJ (PRWEB) July 24, 2014 As part of the long-term strategic approach, DZS expects to manage numerous projects in the MENA region during 2014 with potential global expansion. "We are delighted to have a...

2014-07-24 23:11:58

On July 19, healthcare professionals and consumers were notified not to use drugs marketed as sterile produced by Downing Labs LLC, aka NuVision Pharmacy, as they may be contaminated. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) July 24, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on Sterile Drug...

2014-07-24 23:08:33

This webinar will provide best practice insights into dose selection for First in Human (FIH) dose escalation studies to mitigate risk and optimize the value of your early clinical data. The live broadcast will be taking place on Wednesday, August 6, 2014 @ 10am EDT / 3pm BST (UK GMT +1). Toronto, Canada (PRWEB) July 24, 2014 The first part of the session on “Best Practices for Optimizing Dose Escalation in First in Human Studies” will cover comprehensive clinical support in early...

2014-07-24 16:27:50

SOUTH PLAINFIELD, N.J., July 24, 2014 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the Company will host a webcast conference call to report its second quarter 2014 financial results and provide an update on the company's business and outlook on Thursday, August 7, 2014 at 8:30 a.m. (ET) before the opening of the market. http://photos.prnewswire.com/prnvar/20010919/PTCLOGO The call can be accessed by dialing (877) 303-9216 (domestic) or (973) 935-8152...

2014-07-24 08:35:27

BETHESDA, Md., July 24, 2014 /PRNewswire-USNewswire/ -- The Parenteral Drug Association (PDA) announced today that 31 of its Training and Research Institute (TRI) courses are now listed with the U.S. General Services Administration (GSA) under a Federal Supply Schedule contract. http://photos.prnewswire.com/prnvar/20130226/DC66667LOGO The 31 courses will be included on the GSA Advantage, GSA's online shopping and ordering system https://www.gsaadvantage.gov/advantage/main/start_page.do)....

2014-07-24 08:34:26

Demonstrates Ability of FOCUS Lens Array Technology to Treat Additional High-Volume Indications WESTFORD, Mass., July 24, 2014 /PRNewswire/ -- Cynosure, Inc. (NASDAQ: CYNO), a leader in laser- and light-based aesthetic treatments for non-invasive and minimally invasive applications, today announced that it has received FDA 510(k) clearance to market its flagship PicoSure(TM) Picosecond Laser Workstation for the treatment of acne scars with the FOCUS lens array, the Company's new...

2014-07-24 08:33:44

Based on encouraging progression-free survival data, Lpath extends the study to a second cohort and considers additional proof-of-concept studies SAN DIEGO, July 24, 2014 /PRNewswire/ -- Lpath, Inc. (NASDAQ: LPTN), the industry leader in bioactive lipid-targeted therapeutics, reported interim results in a Phase 2a single-arm, open-label trial where ASONEP(TM) is being investigated as a treatment for metastatic renal cell carcinoma (RCC) in patients that have failed at least one...

2014-07-24 08:33:35

MONROVIA, Calif., July 24, 2014 /PRNewswire/ -- Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer, announced that it will release second quarter financial results after market close on Thursday, July 31, 2014. Xencor management will host a webcast and conference call the same day at 4:30 p.m. EDT (1:30 p.m. PDT) to discuss the financial...

2014-07-24 08:31:56

The Shared Investigator Platform, Built as an Industry Utility, Will Help Accelerate the Development of New Medicines TEANECK, N.J., July 24, 2014 /PRNewswire/ -- Cognizant (NASDAQ: CTSH) today announced that it has been selected by TransCelerate BioPharma Inc., a non-profit organization with membership representation from 19 major pharmaceutical companies, to develop a first-of-its-kind, subscription-based platform that will transform the way clinical sites collaborate with...


Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related